Buy or sell WuXi NextCODE stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

WuXi NextCODE Stock

Using genomic information to improve health

Founded

2013

Notable Investors

Sequoia Capital India

Headquarters

Cambridge MA, US

Total Funding

$455M

About WuXi NextCODE Stock

WuXi NextCODE is a fully integrated contract genomics organization building the global standard platform for genomic data. With offices in Shanghai; Kendall Square in Cambridge, Massachusetts; and Reykjavik, Iceland, we serve the leading population genomics, precision medicine, diagnostics and wellness initiatives and enterprises using the genome to improve health around the world. Our capabilities span study design, sequencing, secondary analysis, storage, and interpretation and scalable analytics – all backed by the most proven and widely used technology for organizing, mining and sharing genome sequence data. We are also applying the same capabilities to advance a growing range of sequence-based tests and scans in China. WuXi NextCODE is a WuXi Group company.

Investors

Funding History

October 2013$15.0M
May 2017$75.0M
September 2017$165M
November 2018$200M

Management

CEO

Hannes Thor Smárason

President and Chief Scientific Officer

Jeffrey Gulcher

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from WuXi NextCODE or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo